PlumX Metrics
Embed PlumX Metrics

RNA-binding proteins regulating the CD44 alternative splicing

Frontiers in Molecular Biosciences, ISSN: 2296-889X, Vol: 10, Page: 1326148
2023
  • 3
    Citations
  • 0
    Usage
  • 13
    Captures
  • 1
    Mentions
  • 0
    Social Media
Metric Options:   Counts1 Year3 Year

Metrics Details

Most Recent News

Research from HSE University Yields New Findings on Cancer (RNA-binding proteins regulating the CD44 alternative splicing)

2023 DEC 15 (NewsRx) -- By a News Reporter-Staff News Editor at Clinical Oncology Daily -- Current study results on cancer have been published. According

Review Description

Alternative splicing is often deregulated in cancer, and cancer-specific isoform switches are part of the oncogenic transformation of cells. Accumulating evidence indicates that isoforms of the multifunctional cell-surface glycoprotein CD44 play different roles in cancer cells as compared to normal cells. In particular, the shift of CD44 isoforms is required for epithelial to mesenchymal transition (EMT) and is crucial for the maintenance of pluripotency in normal human cells and the acquisition of cancer stem cells phenotype for malignant cells. The growing and seemingly promising use of splicing inhibitors for treating cancer and other pathologies gives hope for the prospect of using such an approach to regulate CD44 alternative splicing. This review integrates current knowledge about regulating CD44 alternative splicing by RNA-binding proteins.

Provide Feedback

Have ideas for a new metric? Would you like to see something else here?Let us know